Related Experiment Videos
[Utilization of yeast mutants with a defect in the cellular membrane in the search for anticancer antibiotics]
Abstract:
The mutants of Saccharomyces cerevisiae, strain FL 599-I B with defect cell membranes are selectively inhibited by anticancer antibiotics with different molecular mechanisms of action on DNA. At the same time they are insensitive to antibacterial antibiotics. Such mutants may be used as test-cultures in isolation of active agents with antitumor effect from complex mixtures of natural substances. The above test-object makes it easier to perform separation of antimour antibiotics from accompanying bacterial inhibitors.
Insights
Mutant yeast with defective cell membranes are inhibited by anticancer drugs but not antibacterial ones. These yeast mutants can help isolate antitumor compounds from natural mixtures.
Area of Science:
- Microbiology
- Molecular Biology
- Biochemistry
Background:
- Saccharomyces cerevisiae mutants with cell membrane defects exhibit unique sensitivities to certain compounds.
- Anticancer antibiotics target DNA, while antibacterial antibiotics have different mechanisms.
- Isolating specific bioactive compounds from complex natural mixtures presents a significant challenge.
Purpose of the Study:
- To investigate the selective sensitivity of Saccharomyces cerevisiae mutants (strain FL 599-I B) with defective cell membranes to anticancer and antibacterial antibiotics.
- To evaluate the potential of these specific yeast mutants as test cultures for the isolation of antitumor agents.
- To determine if these mutants can facilitate the separation of antitumor antibiotics from bacterial inhibitors.
Main Methods:
- Utilizing Saccharomyces cerevisiae strain FL 599-I B with known cell membrane defects.
- Testing the selective inhibition of these mutants by various anticancer antibiotics with DNA-targeting mechanisms.
- Assessing the insensitivity of the mutants to antibacterial antibiotics.
- Employing the mutants as test cultures for isolating active agents from natural substance mixtures.
Main Results:
- The selected Saccharomyces cerevisiae mutants demonstrated selective inhibition by anticancer antibiotics.
- These mutants were insensitive to antibacterial antibiotics.
- The mutants proved effective as test cultures for isolating antitumor compounds.
- The use of these mutants simplified the separation of antitumor antibiotics from bacterial inhibitors.
Conclusions:
- Saccharomyces cerevisiae mutants with cell membrane defects offer a selective biological system for identifying anticancer compounds.
- These mutants can serve as valuable tools in the discovery and isolation of novel antitumor agents from natural sources.
- The differential sensitivity of these mutants aids in distinguishing antitumor antibiotics from antibacterial substances.